Skip to main content
Journal cover image

Repeat administration of triamcinolone acetonide extended-release affords consistent, clinically relevant improvements in pain: results from a phase 3B, single-arm, open-label study

Publication ,  Conference
Gomoll, A; Spitzer, A; Richmond, JC; Kraus, VB; Jones, DG; Huffman, KM; Cinar, A; Lufkin, J; Kelley, S
Published in: Osteoarthritis and Cartilage
April 2019

Duke Scholars

Published In

Osteoarthritis and Cartilage

DOI

ISSN

1063-4584

Publication Date

April 2019

Volume

27

Start / End Page

S505 / S506

Publisher

Elsevier BV

Related Subject Headings

  • Arthritis & Rheumatology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 1106 Human Movement and Sports Sciences
  • 1103 Clinical Sciences
  • 0903 Biomedical Engineering
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gomoll, A., Spitzer, A., Richmond, J. C., Kraus, V. B., Jones, D. G., Huffman, K. M., … Kelley, S. (2019). Repeat administration of triamcinolone acetonide extended-release affords consistent, clinically relevant improvements in pain: results from a phase 3B, single-arm, open-label study. In Osteoarthritis and Cartilage (Vol. 27, pp. S505–S506). Elsevier BV. https://doi.org/10.1016/j.joca.2019.02.570
Gomoll, A., A. Spitzer, J. C. Richmond, V. B. Kraus, D. G. Jones, K. M. Huffman, A. Cinar, J. Lufkin, and S. Kelley. “Repeat administration of triamcinolone acetonide extended-release affords consistent, clinically relevant improvements in pain: results from a phase 3B, single-arm, open-label study.” In Osteoarthritis and Cartilage, 27:S505–6. Elsevier BV, 2019. https://doi.org/10.1016/j.joca.2019.02.570.
Gomoll A, Spitzer A, Richmond JC, Kraus VB, Jones DG, Huffman KM, et al. Repeat administration of triamcinolone acetonide extended-release affords consistent, clinically relevant improvements in pain: results from a phase 3B, single-arm, open-label study. In: Osteoarthritis and Cartilage. Elsevier BV; 2019. p. S505–6.
Gomoll, A., et al. “Repeat administration of triamcinolone acetonide extended-release affords consistent, clinically relevant improvements in pain: results from a phase 3B, single-arm, open-label study.” Osteoarthritis and Cartilage, vol. 27, Elsevier BV, 2019, pp. S505–06. Crossref, doi:10.1016/j.joca.2019.02.570.
Gomoll A, Spitzer A, Richmond JC, Kraus VB, Jones DG, Huffman KM, Cinar A, Lufkin J, Kelley S. Repeat administration of triamcinolone acetonide extended-release affords consistent, clinically relevant improvements in pain: results from a phase 3B, single-arm, open-label study. Osteoarthritis and Cartilage. Elsevier BV; 2019. p. S505–S506.
Journal cover image

Published In

Osteoarthritis and Cartilage

DOI

ISSN

1063-4584

Publication Date

April 2019

Volume

27

Start / End Page

S505 / S506

Publisher

Elsevier BV

Related Subject Headings

  • Arthritis & Rheumatology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 1106 Human Movement and Sports Sciences
  • 1103 Clinical Sciences
  • 0903 Biomedical Engineering